[1]
Das, D.; Hong, J. Recent Progress and Development of Small Molecule Kinase Inhibitors for the Treatment of Breast Cancer. Curr. Enzym. Inhib., 2020, 16(1), 4-19.
[2]
Makar, S.; Ghosh, A.; Kumar, A.; Singh, S.K. Recent Studies on Aromatase and Sulfatase Involved in Breast Cancer and their Inhibitors. Curr. Enzym. Inhib., 2020, 16(1), 20-44.
[3]
Ghuge, R.B.; Murumkar, P.R.; Choudhary, K.M.; Joshi, K.D.; Chauhan, M.; Barot, R.R.; Yadav, M.R. Development of Steroidal Aromatase Inhibitors as Potential Anti-breast Cancer Agents. Curr. Enzym. Inhib., 2020, 16(1), 45-62.
[4]
Kaushik, R.; Khan, S.; Sharma, M.; Hemalatha, S.; Mueed, Z.; Poddar, N.K. Role of Cytochrome P450 in Prostate Cancer and its Therapy. Curr. Enzym. Inhib., 2020, 16(1), 63-73.
Current Enzyme Inhibition
Title:Recent Studies on Inhibition of Enzymes Leading to Prostate and Breast Cancers
Volume: 16 Issue: 1
Author(s): Satya P. Gupta
Affiliation:
Export Options
About this article
Cite this article as:
Gupta P. Satya , Recent Studies on Inhibition of Enzymes Leading to Prostate and Breast Cancers, Current Enzyme Inhibition 2020; 16 (1) . https://dx.doi.org/10.2174/157340801601200416074726
DOI https://dx.doi.org/10.2174/157340801601200416074726 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
20
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of EGFR Inhibitors in the Treatment of Central Nervous System Metastases from Non-Small Cell Lung Cancer
Current Cancer Drug Targets Preparation and Surface Modification of Polymeric Nanoparticles for Drug Delivery: State of the Art
Recent Patents on Drug Delivery & Formulation Strategies for Conjugation of Biomolecules to Nanoparticles as Tumor Targeting Agents
Current Pharmaceutical Design Present Drug Therapy of Demyelinating Disorders
Current Drug Therapy Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases
Current Medicinal Chemistry Intestinal Absorption and Presystemic Elimination of Various Chemical Constituents Present in GBE50 Extract, a Standardized Extract of Ginkgo biloba Leaves
Current Drug Metabolism Targeting ErbB Receptors in High-Grade Glioma
Current Pharmaceutical Design Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer
Reviews on Recent Clinical Trials Urokinase Receptor and Integrin Interactions
Current Pharmaceutical Design Hemolytic Uremic Syndrome in Children
Current Pediatric Reviews Synthesis and Anticancer Evaluation of some Newer 2, 5-Disubstituted-1,3, 4-Oxadiazole Analogues
Letters in Drug Design & Discovery Novel Orphan Nuclear Receptors-Coregulator Interactions Controlling Anti-Cancer Drug Metabolism
Current Drug Metabolism Genetics and Ulcerative Colitis: What are the Clinical Implications?
Current Drug Targets The Role of Image Guided Radiotherapy in the Treatment of Soft Tissue Sarcoma
Current Cancer Therapy Reviews Novel Oral Anticoagulants: Recommendations for Patient Evaluation, Treatment Initiation, Follow-up and Perioperative Management
Cardiovascular & Hematological Disorders-Drug Targets Reprofiling of Troglitazone Towards More Active and Less Toxic Derivatives: A New Hope for Cancer Treatment?
Current Topics in Medicinal Chemistry Breast Cancer Stem Cells and Sex Steroid Hormones
Current Stem Cell Research & Therapy Characterization of Liver- and Cancer-type-Organic Anion Transporting Polypeptide (OATP) 1B3 Messenger RNA Expression in Normal and Cancerous Human Tissues
Drug Metabolism Letters Comparison of the Growth Curves of Cancer Cells and Cancer Stem Cells
Current Stem Cell Research & Therapy Targeting Oncogenes and Tumor Suppressors genes to Mitigate Chemoresistance
Current Cancer Drug Targets